Company: DKI
Filing Date: 2025-07-29
Form Type: F-1/A
Source: 0001641172-25-021310
Chunk: 11

Company: DarkIris Inc.
Filing Date: 2025-07-29
Form: F-1/A
Chunk 11
---
 the disclosures beginning on page 4 of this prospectus for more information.

Neither the U.S. Securities and Exchange Commission nor any state securities commission nor any other regulatory body has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

Investing in our Class A Ordinary Shares involves a high degree of risk, including the risk of losing your entire investment. See “Risk Factors” beginning on page 12 of this prospectus to read about factors you should consider before buying our Class A Ordinary Shares.

|                                 |     | PER   
 SHARE |      |     | TOTAL(4) |           |
|:--------------------------------|:----|:------|-----:|:----|:---------|----------:|
| Initial                         
 public offering price           |     | $     | 4.00 |     | $        | 6,000,000 |
| Underwriting                    
 discounts and commissions(1)(2) |     | $     | 0.28 |     | $        |   420,000 |
| Proceeds,                       
 before expenses, to us          |     | $     | 3.72 |     | $        | 5,580,000 |

| (1) | The underwriters will                                                                                                                 
 receive compensation in addition to the discounts and commissions. For a description of compensation payable to the underwriters, see 
 “Underwriting” beginning on page 110.                                                                                                 |

| (2) | Does not include a non-accountable                                                                                                  
 expense allowance equal to $60,000, equal to one percent (1%) of the gross proceeds received by us from this offering, payable      
 to the underwriters, or the reimbursement of certain expenses of the underwriters. For a description of other terms of compensation 
 to be received by the underwriters, see “Underwriting” beginning on page 110.                                                       |
| (3) | Based                                                                                                                               
 on an assumed initial public offering price of $4 per share.                                                                        |
| (4) | Assumes that the underwriters                                                                                                       
 do not exercise any portion of their over-allotment option.                                                                         |

We expect our total cash expenses for this offering (including cash expenses payable to our underwriters for their out-of-pocket expenses) to be approximately $1.3 million, exclusive of the above discounts and commissions. These payments will further reduce proceeds available to us before expenses. See “Underwriting.”

This offering is being conducted on a